Physician profile
Atreya Dash
NPI 1578768255
$1,712.42
in general payments reported to CMS, 2019-2025
8 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $1,168 · 2021: $3.82 · 2023: $15.00 · 2024: $125 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,168.39 | 2020 | |
| Photocure INC | $170.87 | 2019 | |
| Janssen Scientific Affairs, LLC | $124.44 | 2025 | Erleada |
| Urogen Pharma, INC. | $111.80 | 2024 | |
| Olympus America INC. | $104.60 | 2025 | Itind System |
| Boston Scientific Corporation | $28.50 | 2023-2024 | Spaceoar Vue System - 10ml |
| Travere Therapeutics, INC. | $3.82 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atreya Dash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.